Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thrombin Generation Parameters and Bleeding Risk in Cancer Associated Thrombosis
NCT06386107Recruiting
- Sponsor
- CHU Saint-Etienne
- Start
- Sep 2025
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHU Saint-Etienne. Primary endpoints: Area Under the Curve (Endogenous Thrombin Potential) at 6 months, Lag Time at 6 months and 2 more. Started Sep 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06386107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06386107.